在健康个体的mRNA疫苗接种后,长度蛋白质和自身抗体特征

Blandine Chazarin1, Archana Subramanya Bhat2, Niveda Sundararaman2

  • 1Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA; Advanced Clinical Biosystems Research Institute, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA; Proteomic and Microbiology Department, UMONS, Mons, Belgium.

Vaccine
|November 28, 2025
PubMed
概括

接种SARS-CoV-2mRNA疫苗会产生持久的尖端特异性抗体和免疫变化,包括补体激活,在接种疫苗后长达24周. 这项研究证实了在有限的自身抗体诱导下疫苗的安全性.